Cargando…
Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
Considering that osteoarthritis (OA) is the most prevalent joint disease worldwide, multiple pharmacological treatments have been proposed to alter the articular structure with potential benefit in the progression of the disease. The so-called disease-modifying OA drugs have been frequently investig...
Autores principales: | Rodrigues, T.A., Freire, A.O., Bonfim, B.F., Cartágenes, M.S.S., Garcia, J.B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040865/ https://www.ncbi.nlm.nih.gov/pubmed/29924137 http://dx.doi.org/10.1590/1414-431X20187440 |
Ejemplares similares
-
Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
por: Rodrigues, T.A., et al.
Publicado: (2017) -
Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
por: Rodrigues, Thiago A., et al.
Publicado: (2018) -
Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
por: Paulino Silva, Kássya Mycaela, et al.
Publicado: (2021) -
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014)